The Pharmacy Times® ADHD resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
It is critical to stress that Attention-Deficit/Hyperactivity Disorder is probably a lifelong condition for most individuals with the condition.
March 29 Pharmacy Week in Review: Study Evaluates Risk of Psychosis in Young Patients with ADHD, Long-Term Survival May Be Associated with MS Treatment
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
The prescription of stimulants for the treatment of attention deficit-hyperactivity disorder (ADHD) is increasing among adolescents and young adults, and a new study sheds light on possible safety concerns.
The drug's approval was based on 4 clinical studies evaluating the efficacy and safety of Adhansia XR in 883 people who met DSM-5 criteria for ADHD.
Within the group of Spanish patients with ADHD, a specific variation of the LPHN3 gene increased by 40% the risk of nicotine dependence.
Under the settlement and license agreement, Neos has granted Teva the right to manufacture and market its generic version of Cotempla XR-ODT® under the Teva ANDA beginning on July 1, 2026, or earlier under certain circumstances.
Canine animal assistance improves attentiveness and social skills in children with ADHD, according to recent study.
A recent study found that athletes with attention deficit hyperactivity disorder (ADHD) may need to be even more cautious in concussion prevention.
Both asthma and attention-deficit/hyperactivity disorder (ADHD), both chronic conditions, have been associated with each other in previous studies, but questions remained as to the strength of the association because of other possible confounders.
New research suggests psychiatric diseases that affect a patientâ€™s ability to appropriately respond to stimuli may be triggered by the misplacement of an enzyme in the pathway within neurons.
New research suggests psychiatric diseases, including ADHD, that affect a patient’s ability to appropriately respond to stimuli may be triggered by the misplacement of an enzyme in the pathway within neurons.